全球潮热治疗市场 – 行业趋势和 2030 年预测

潮热治疗市场分析和规模

预计全球潮热治疗市场将在预测期内出现显著增长。女性人口的增加本身就是潮热治疗增长的最大机遇。潮热被认为是更年期最常见的症状。约 65% 的女性抱怨潮热超过两年，36% 的女性抱怨潮热超过五年。

Data Bridge Market Research 分析了 2023-2030 年预测期内全球潮热治疗市场的增长率。在上述预测期内，全球潮热治疗市场的预期复合年增长率约为 7%。2022 年市场价值为 122 亿美元，到 2030 年将增长至 209.6 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

潮热治疗市场范围和细分

Market Definition

Hot flashes are typically characterized by sudden mild or intense body heat because of the changes occurrence by hormones. This occurs due to decreased level of estrogens. The phenomenon of host flashes in men, young women, or pregnant ladies is projected because of medical conditions that may also disrupt the body’s ability to regulate temperature. It is mostly seen in menopause conditions. The hot flashes are generally belief to be lasting for 30 minutes. The common symptoms associated with hot flashes include feeling of anxiety, rapid heartbeat, perspiration on upper body, red and blotchy skin and palpitations.

Global Hot Flashes Treatment Market Dynamics

Drivers

• Increasing Prevalence of Hot Flashes Symptoms

As per the study "Hot Flashes" updated in December 2021 published in the National Center for Biotechnology Information (NCBI), hot flashes were among the most common types of menopausal vasomotor (VMS) symptoms, which is affecting up to 74% of perimenopausal women. Around 65% of women complain of hot flashes for more than two years and 36% cry for more than five years. Thus, this acts as a major factor boosting the market growth.

• Launch of Numerous Drugs Associated with Hot flashes

There has been several drug launches helping in treating this condition that are boosting the market growth. For instance, Novartis AG provides "Vivelle-DOT (estradiol transdermal system)" used to treat moderate and severe vasomotor symptoms because of menopause and to treat moderate to severe symptoms of vulvar and vaginal atrophy. In addition to this, the company Novo Nordisk Corporation launched a "Vagifem" 10 mcg tablet for vagin that treats changes in and around the vagina that generally occur after menopause and treats a combination of vaginal symptoms. Thus, it boosts the market growth.

Opportunities

• Increased Clinical Studies and Government Initiatives

The growing focus on research and development of treatment of hot flashes is pushing the growth of the market. For instance, in December 2021, Acer Therapeutics Inc. received U.S. FDA clearance of its Investigational New Drug (IND) application for its selective non-peptide neurokinin 3 receptors (NK3R) antagonist, ACER-801 (osanetant), for the potential treatment of induced Vasomotor Symptoms (iVMS).

• Increasing Awareness of Hot Flashes

The stakeholders in the hot flashes treatment market are working diligently towards spreading the awareness regarding the menopause, and trying to address the stigma associated with it, by launching numerous social media campaigns about the health issues related to menopause. The main aim is to literate the female population, also helping the players promote alternative solutions for managing hot flashes.

 Restraints/Challenges

• Risk of Complications

There are high risk of complications associated with the hot flashes treatment. Complications such as headache, upset stomach, vomiting, stomach cramps, appetite and weight changes and many others are witnessed post the therapy. Thus, it hampers the market growth.

• High Cost

The huge expenditure associated with these therapies hamper the market growth. The hormonal treatment definitely involves a heavy cost and thus hampers the market growth.

This global hot flashes treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hot flashes treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Hot Flashes Treatment Market  

The COVID-19 epidemic has affected the supply chain of several pharmaceutical products. The restrictions associated with the production and export of medicines have largely affected many imported products, such as the U.S., Europe, and other countries. During this period, several pharmaceutical companies manufacture some of the medicines indoors, and some of the company's medicines are manufactured with foreign materials, such as contract production services, which also contributed to the supply of products. As per a study titled "Inactive Lifestyles Lead to More Frequent, Severe Hot Flashes: Study" published in September 2021, in the age of COVID-19, sedentary behavior, working from home, traveling less has increased the incidence of hot flashes and menopause in women, which has majorly impacted the market.

Global Hot Flashes Treatment Market Scope

The global hot flashes treatment market is segmented on the basis of type, route of administrtaion, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Hormonal Treatment
• Estrogen
• Progesterone
• Estrogen-Progesterone Combination
• Non-Hormonal Treatment
• Antidepressant
• Other Non-hormonal Treatments

Route of Administration

• Oral
• Parenteral

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Hot Flashes Treatment Market Regional Analysis/Insights

The global hot flashes treatment market is analyzed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global hot flashes treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global hot flashes treatment market throughout the forecast period due to increased new research and developments on hot flashes treatment market.

Asia-Pacific dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Hot Flashes Treatment Market Share Analysis

The global hot flashes treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hot flashes treatment market

Key players operating in the global hot flashes treatment market include:

• AbbVie Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Cipla Inc. (India)
• Lupin (India)
• Sun Pharmaceuticals Industries Ltd. (India
• Hikma Pharmaceuticals PLC (U.K.)
• Boehringer Ingelheim International GmbH (Germany)
• Sanofi (France)
• AstraZeneca (U.K.)
• GSK Plc. (U.K.)
• Pfizer Inc. (U.S.)
• Novartis AG (Switzerland)
• Mylan NV（美国）
• 久光制药株式会社（日本）
• 默克公司（美国）
• TherapeuticsMD, Inc（美国）
• 礼来（美国）
• Emcure Pharmaceuticals Limited（印度）
• 拜耳公司（德国）

研究方法：全球潮热治疗市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

SKU-55993